These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26202679)

  • 1. Epithelial-mesenchymal transition and drug resistance in breast cancer (Review).
    Huang J; Li H; Ren G
    Int J Oncol; 2015 Sep; 47(3):840-8. PubMed ID: 26202679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
    Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
    Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.
    Foroni C; Broggini M; Generali D; Damia G
    Cancer Treat Rev; 2012 Oct; 38(6):689-97. PubMed ID: 22118888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells.
    Yang Q; Wang Y; Lu X; Zhao Z; Zhu L; Chen S; Wu Q; Chen C; Wang Z
    Oncotarget; 2015 Feb; 6(5):3268-79. PubMed ID: 25605244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of miR-155 in drug resistance of breast cancer.
    Yu DD; Lv MM; Chen WX; Zhong SL; Zhang XH; Chen L; Ma TF; Tang JH; Zhao JH
    Tumour Biol; 2015 Mar; 36(3):1395-401. PubMed ID: 25744731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
    Du B; Shim JS
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen.
    Li Q; Chen C; Kapadia A; Zhou Q; Harper MK; Schaack J; LaBarbera DV
    J Biomol Screen; 2011 Feb; 16(2):141-54. PubMed ID: 21297102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of gene expression in MDA-MB-453 breast cancer cell line in response to continuous exposure to Trastuzumab.
    Sharieh EA; Awidi AS; Ahram M; Zihlif MA
    Gene; 2016 Jan; 575(2 Pt 2):415-420. PubMed ID: 26367328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
    Glackin CA
    Enzymes; 2018; 44():83-101. PubMed ID: 30360816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.
    Si L; Jiang F; Li Y; Ye X; Mu J; Wang X; Ning S; Hu C; Li Z
    Mol Carcinog; 2015 Sep; 54(9):859-69. PubMed ID: 24729530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway.
    Li H; Huang J; Yang B; Xiang T; Yin X; Peng W; Cheng W; Wan J; Luo F; Li H; Ren G
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):180-90. PubMed ID: 23707762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
    Garg M
    Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
    Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells.
    Nandy SB; Gangwani L; Nahleh Z; Subramani R; Arumugam A; de la Rosa JM; Lakshmanaswamy R
    Future Oncol; 2015; 11(6):983-95. PubMed ID: 25760978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy.
    Piva F; Giulietti M; Santoni M; Occhipinti G; Scarpelli M; Lopez-Beltran A; Cheng L; Principato G; Montironi R
    Mol Diagn Ther; 2016 Apr; 20(2):111-7. PubMed ID: 26940073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell.
    Liu H; Gu Y; Yin J; Zheng G; Wang C; Zhang Z; Deng M; Liu J; Jia X; He Z
    Cell Signal; 2014 Dec; 26(12):2710-20. PubMed ID: 25152373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer cells: Focus on the consequences of epithelial-to-mesenchymal transition.
    Bong AHL; Monteith GR
    Int J Biochem Cell Biol; 2017 Jun; 87():23-26. PubMed ID: 28336365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of epithelial-mesenchymal transition in cancer drug resistance.
    Shang Y; Cai X; Fan D
    Curr Cancer Drug Targets; 2013 Nov; 13(9):915-29. PubMed ID: 24168191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines.
    Fu P; Du F; Chen W; Yao M; Lv K; Liu Y
    Oncol Rep; 2014 Jun; 31(6):2561-8. PubMed ID: 24737252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.